Atorvastatin Treatment for Men with Lower Urinary Tract Symptoms and Benign Prostatic Enlargement

This publication has 25 references indexed in Scilit:

• The Efficacy of Drugs for the Treatment of LUTS/BPH, A Study in 6 European Countries
  European Urology, 2007
• The Detrusor Muscle: An Innocent Victim of Bladder Outlet Obstruction
  European Urology, 2007
• Anticholinergic Drugs in Patients with Bladder Outlet Obstruction and Lower Urinary Tract Symptoms: A Systematic Review
  European Urology, 2006
• High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
  New England Journal of Medicine, 2006
• High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial InfarctionThe IDEAL Study: A Randomized Controlled Trial
  JAMA, 2005
• Medical Consumption and Costs during a One-Year Follow-up of Patients with LUTS Suggestive of BPH in Six European Countries: Report of the TRIUMPH Study
  European Urology, 2005
• Relative Efficacy of Atorvastatin 80 mg and Pravastatin 40 mg in Achieving the Dual Goals of Low-Density Lipoprotein Cholesterol <70 mg/dl and C-Reactive Protein <2 mg/l
  Journal of the American College of Cardiology, 2005
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
  The Lancet, 2004
• Y-27632, A Rho-Kinase Inhibitor, Inhibits Proliferation and Adrenergic Contraction of Prostatic Smooth Muscle Cells
  Journal of Urology, 2003
• Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
  The Lancet, 2003